Restructuring (Tables)

3 Months Ended

May 30, 2020

Restructuring

Schedule of restructuring-related costs

For the thirteen week period ended May 30, 2020, the Company incurred total restructuring-related costs of $35,735, of which $9,972 is included as a component of SG&A and $25,763 is included as a component of cost of revenues. These costs are as follows:

	Retail Pharmacy		Pharmacy
	segment		Services segment		Total
Restructuring-related costs
Severance and related costs associated with ongoing reorganization efforts (a)	$	4,559	$	252	$	4,811
Non-executive retention costs associated with the March 2019 reorganization (b)		855		(226)		629
Professional and other fees relating to restructuring activities (c)		4,532		—		4,532
SKU optimization charges (d)		25,763		—		25,763
Total restructuring-related costs	$	35,709	$	26	$	35,735

For the thirteen week period ended June 1, 2019, the Company incurred total restructuring-related costs of $43,350, which are included as a component of SG&A. These costs are as follows:

	Retail Pharmacy		Pharmacy
	segment		Services segment		Total
Restructuring-related costs
Severance and related costs associated with ongoing reorganization efforts (a)	$	25,272	$	1,804	$	27,076
Non-executive retention costs associated with the March 2019 reorganization (b)		4,499		2,165		6,664
Professional and other fees relating to restructuring activities (c)		9,610		—		9,610
Total restructuring-related costs	$	39,381	$	3,969	$	43,350

Schedule of restructuring-related liabilities

	Severance and related				Professional and
	costs (a)		Retention costs (b)		other fees (c)		Total
Balance at February 29, 2020	$	36,228	$	6,432	$	2,394	$	45,054
Additions charged to expense		4,811		629		4,532		9,972
Cash payments		(13,055)		—		(5,046)		(18,101)
Balance at May 30, 2020	$	27,984	$	7,061	$	1,880	$	36,925

(a) – Severance and related costs reflect severance accruals, executive search fees, outplacement services and other similar charges associated with ongoing reorganization efforts.

(b) – As part of its March 2019 reorganization, the Company incurred costs with the implementation of a retention plan for certain of its key associates.

(c) – Professional and other fees include costs incurred in connection with the identification and implementation of initiatives associated with restructuring activities.

(d) – Inventory reserve on product lines the Company is exiting and will no longer carry as part of its rebranding initiative.